![]() |
市场调查报告书
商品编码
1402026
到 2030 年医疗美容市场预测:按产品、程序、应用、最终用户和地区进行的全球分析Medical Aesthetics Market Forecasts to 2030 - Global Analysis By Product, Procedure, Application, End User and by Geography |
根据 Stratistics MRC 的数据,2023 年全球医学美容市场规模为 234.6 亿美元,预计预测期内复合年增长率为 14.2%,到 2030 年将达到 594.2 亿美元。
医学美容是一个医学领域,专注于透过微创和非侵入性美容手术来改善患者的外观。这些手术旨在治疗皱纹、细纹、皮肤下垂和多余脂肪等问题,改善脸部和身体的外观。此外,用于减少老化征兆的肉毒桿菌和真皮填充剂等注射、用于嫩肤和除毛的雷射治疗以及非手术身体轮廓技术都是常见的医学美容治疗的例子。
根据 BAAPS 2021 年 2 月发布的研究报告,2021 年英国进行了 15,405 例整容手术。随着美容疗程的增多,需要医疗美容设备。这创造了对医疗美容设备的需求并推动市场成长。
老化进展
医疗美容设备市场很大程度上是由世界老龄化人口的增加所推动的。皱纹、细纹和皮肤弹性丧失是随着老龄化而自然发生的老化症状的例子。此外,由于人们渴望看起来更年轻以及美容手术的进步,因此对与老龄化相关的美容问题的治疗也有很高的需求。
不利情况或问题的风险
由于医疗和美容手术存在不良结果和併发症的固有风险,潜在患者可能会犹豫不决。儘管安全标准已经取得了长足的进步,但无论是真实的还是想像的併发症,都可能会损害大众的信任。此外,为了缓解这一限制,行业相关人员必须高度重视开放性、全面的患者教育和安全协议的持续改进。
创新和技术进步
不断的创新和技术的进步为医美市场带来了巨大的机会。透过结合机器学习 (ML)、扩增实境(AR) 和人工智慧 (AI),治疗计划和模拟变得更加准确和个体化。此外,基于能量的平台和先进雷射等创新设备的开发为微创和非侵入性手术开闢了新途径。
景气衰退和消费者支出下降
消费者在医疗和美容等非必需服务上的支出可能会受到景气衰退、衰退和全球金融危机的影响。由于其对可支配收入变化的敏感性,该行业很容易在经济衰退期间受到需求减少的影响。此外,为了抵御此威胁,必须制定策略并修改行销方法,以提高经济不确定时期的抵御能力。
医疗美容市场受到COVID-19大流行的严重影响。在大流行初期,政府封锁、选择性手术的限制以及安全问题的加剧导致患者就诊量和手术量大幅下降。该行业经历了诊所关闭、供应链中断以及消费者基本医疗保健优先事项的转变。不过,随着限制的放鬆,美容服务的需求逐渐恢復。此外,疫情加速了虚拟就诊和远端医疗的普及,改变了病患的互动。
预计预测期内乳房植入手术领域规模最大
隆乳占据美容市场的最大份额。隆乳是一种使用植入或脂肪移植来增加乳房的大小和形状的外科手术。乳房植入物的吸引力在于它们可以缓解美容问题并提高自尊。此外,这种手术在美容行业的持续流行是由于多种因素造成的,包括不断发展的美容标准、不断提高的身体积极性以及手术技术的改进。
诊所、医院和医疗水疗产业预计在预测期内复合年增长率最高
预计医疗水疗领域在整个预测期内将呈现最高的复合年增长率。医疗水疗中心将传统水疗特色与经过认证的医疗保健专业人员管理的医疗服务相结合,提供全面的美容护理方法。它的吸引力在于提供最先进的美容疗程以及放鬆和健康服务,为客户提供独特而全面的体验。此外,医疗水疗模式具有很高的成长潜力,因为它经常吸引多样化的客户在类似水疗的环境中寻求非侵入性治疗。
预计北美将占据全球美容产业的最大份额。特别是在美国,各种美容手术的需求旺盛,市场成长显着。该地区的繁荣得益于发达的医疗体系、高度的美容意识以及对外表和美丽的重视。此外,雷射治疗、活肤、身体轮廓、脸部注射和其他手术都是北美提供的各种美容手术的一部分。
复合年增长率最高的亚太地区是全球美容市场的一支生力军。不断壮大的中产阶级、不断变化的美容标准以及不断增长的可支配收入,都导致中国、日本和韩国等国家的整容手术需求激增。此外,该地区对非侵入性手术的快速采用和对美容的文化接受度正在将该地区推向行业的前沿。
According to Stratistics MRC, the Global Medical Aesthetics Market is accounted for $23.46 billion in 2023 and is expected to reach $59.42 billion by 2030 growing at a CAGR of 14.2% during the forecast period. Medical aesthetics is a field of medicine that focuses on improving a patient's appearance using a range of minimally invasive and non-invasive cosmetic procedures. With the aim of treating issues like wrinkles, fine lines, sagging skin, and extra fat, these procedures aim to enhance the appearance of the face and body. Moreover, injectables like Botox and dermal fillers, which lessen signs of aging, laser therapy for skin rejuvenation and hair removal, and non-surgical body contouring techniques are examples of common medical aesthetic treatments.
According to the BAAPS survey released in February 2021, 15,405 cosmetic surgical procedures were performed in the United Kingdom in 2021. The increasing number of aesthetic procedures requires medical aesthetic devices. This is creating the need for medical aesthetic devices and driving the market's growth.
Increasingly aging population
The market for medical aesthetics is largely driven by the global increase in the aging population. Wrinkles, fine lines, and a decrease in skin elasticity are examples of the natural progression of signs of aging that occur as people age. Additionally, treatments for age-related cosmetic concerns are in high demand due to the desire to look youthful and the advancements in aesthetic procedures.
Hazard of unfavorable circumstances and issues
Potential patients may hesitate due to the inherent risk of unfavorable outcomes or complications from medical aesthetic procedures. Safety standards have come a long way, but incidents of complications-real or imagined-can undermine public confidence. Furthermore, in order to alleviate this constraint, industry stakeholders need to place a high priority on openness, comprehensive patient education, and ongoing safety protocol improvement.
Innovation and technological advancements
Continuous innovations and advancements in technology offer the medical aesthetics market a sizable opportunity. Treatment planning and simulations are made more accurate and individualized by incorporating machine learning (ML), augmented reality (AR), and artificial intelligence (AI). Additionally, new paths for minimally invasive and non-invasive procedures are opened by the development of innovative devices like energy-based platforms and sophisticated lasers.
Economic downturns and declines in consumer spending
Consumer expenditure on non-essential services, such as medical aesthetics, can be impacted by economic downturns, recessions, or global financial crises. Due to its sensitivity to changes in disposable income, the industry is susceptible to a decline in demand during recessions. Moreover, to navigate this threat, it is imperative to develop resilience strategies and modify marketing approaches during periods of economic uncertainty.
The market for medical aesthetics has been significantly impacted by the COVID-19 pandemic. Early in the pandemic, there was a marked decline in patient visits and procedural volumes due to government-imposed lockdowns, limitations on elective procedures, and increased safety concerns. The industry experienced clinic closures, supply chain disruptions, and changes in consumer priorities toward basic healthcare. Pent-up demand for aesthetic services drove a gradual recovery, nevertheless, as restrictions eased. Additionally, the pandemic hastened the uptake of virtual consultations and telemedicine, which has altered patient interactions.
The Breast Augmentation segment is expected to be the largest during the forecast period
In the aesthetic market, the breast augmentation segment has the largest share. Breast augmentation is the surgical process of using implants or fat transfer to increase the size and shape of the breasts. The allure of breast augmentation is its capacity to alleviate cosmetic issues and enhance self-assurance. Moreover, the sustained popularity of this procedure in the aesthetic industry can be attributed to a number of factors, including evolving standards of beauty, a rise in body positivity, and improvements in surgical techniques.
The Clinics, Hospitals, And Medicals Spas segment is expected to have the highest CAGR during the forecast period
Throughout the forecast period, the medical spa segment is expected to have the highest CAGR. Medical spas provide a comprehensive approach to aesthetic care by combining the features of a traditional spa with medical services managed by certified healthcare professionals. Their appeal lies in offering cutting-edge aesthetic treatments along with relaxation and wellness services, giving customers a one-of-a-kind and all-inclusive experience. Furthermore, the medical spa model has the potential to have high growth because it frequently draws a diverse clientele looking for non-invasive procedures in a spa-like setting.
It is predicted that in the global aesthetic industry, North America will hold the largest share. Particularly in the United States, where there is a strong demand for a variety of aesthetic procedures, the market has grown significantly. A well-established healthcare system, a high degree of awareness regarding cosmetic procedures, and a strong emphasis on appearance and beauty are some of the factors that contribute to the region's prominence. Moreover, laser treatments, skin rejuvenation, body contouring, facial injectables, and other procedures are all part of the wide range of aesthetic procedures offered in North America.
With the highest CAGR, the Asia-Pacific region has become a dynamic force in the global aesthetic market. A growing middle class, changing beauty standards, and rising disposable incomes have all contributed to a boom in the demand for aesthetic procedures in nations like China, Japan, and South Korea. Additionally, the region has advanced to the forefront of the industry due to its quick uptake of non-invasive procedures and cultural acceptance of cosmetic enhancements.
Some of the key players in Medical Aesthetics market include Mentor Worldwide LLC, Lumenis, Bausch Health Companies Inc., Johnson & Johnson Services, Inc., Galderma Laboratories L.P, AbbVie Inc., Merz Pharmaceuticals GmbH, El.En. S.p.A. (Asclepion Laser Technologies), Syneron Medical, Ltd, Deka Laser Technologies, Solta Medical, Inc, Allergan plc, Sientra, Inc., Cynosure Inc., Sharplight Technologies Inc, Alma Lasers and Sciton Inc.
In June 2023, Bausch + Lomb Corporation, a subsidiary of Bausch Health Companies Inc., announced that it has entered into a definitive agreement with Novartis to acquire XIIDRA® 5%, a non-steroid eye drop specifically approved to treat the signs and symptoms of dry eye disease (DED) focusing on inflammation associated with dry eye.
In March 2023, Galderma announced today the launch of FACE by Galderma™, an innovative aesthetic visualization tool powered by augmented reality (AR) that allows aesthetic professionals and patients to visualize injectable treatment results* at the planning stage before treatment begins. This innovative solution gives patients a simulated real-time "before and after" visual of what may be possible from an individualized treatment plan and may help alleviate patient concerns about injectable results.
In January 2023, Pharmaceutical companies AbbVie (ABBV.N) and Eli Lilly have withdrawn from Britain's voluntary medicines pricing agreement, an industry body said on Monday. Companies are increasingly arguing that it is no longer possible to justify the UK's "voluntary scheme" to global boardrooms and investors as repayment rates in 2023 have surged to 26.5% of revenue, the Association of the British Pharmaceutical Industry (ABPI) said in a statement.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.